VR Adviser’s LianBio American Depositary Shares LIAN Stock Holding History

VR Adviser’s Portfolio LIAN Stock Details LIAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-4,793,047	Closed	-$7.86M	–	31
2022 Q4	$7.86M	Sell	4,793,047 -585,294	-11%	-$912K	1.32%	20
2022 Q3	$10.8M	Hold	5,378,341	–	–	1.66%	17
2022 Q2	$11.6M	Hold	5,378,341	–	–	2.29%	15
2022 Q1	$20M	Hold	5,378,341	–	–	3.23%	12
2021 Q4	$33.1M	Buy	+5,378,341	New	+$61.4M	4.53%	11

Other funds holding LIAN

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

TCM

Tybourne Capital Management Hong Kong $30.9M AUM 20.1% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

VVA

Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCHF (GPE) Wilson, Wyoming $781M AUM 24.06% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

VR Adviser's LIAN Position: Q1 2023 in Review

VR Adviser sold out of LianBio American Depositary Shares (LIAN) in Q1 2023, closing a stake of 4,793,047 shares — an estimated $7.86M sold.

VR Adviser first reported a position in LIAN in Q4 2021 and held it in 5 quarters. The position peaked at $33.1M in Q4 2021. 36 funds tracked by Wall St. Rank hold LIAN as of Q1 2023.

VR Adviser reported no remaining LianBio American Depositary Shares position as of Q1 2023 after selling out during the quarter.
VR Adviser sold 4,793,047 LianBio American Depositary Shares shares in Q1 2023, an estimated $7.86M.
VR Adviser first reported a position in LianBio American Depositary Shares in Q4 2021 and held it in 5 quarters.
VR Adviser's LianBio American Depositary Shares position peaked at $33.1M in Q4 2021.
36 funds tracked by Wall St. Rank held LianBio American Depositary Shares as of Q1 2023.

Based on VR Adviser's 13F filing for Q1 2023, filed 15 May 2023.